Cardax Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.03 |
Market Cap |
$13.62 M |
Shares Outstanding |
136.02 M |
Public Float |
108.9 M |
Address |
2800 Woodlawn Drive Honolulu Hawaii 96822 United States |
Employees | - |
Website | http://www.cardaxpharma.com |
Updated | 07/08/2019 |
Cardax, Inc. is a life sciences company, which engages in the development, marketing, and distribution of consumer health products. It focuses on astaxanthin, which is a powerful and safe naturally occurring anti-inflammatory without the side effects of currently marketed anti-inflammatories. The company was founded on February 7, 2014 and is headquartered in Honolulu, HI. |